Drug commercialization company Medical Knowledge Group acquired by Novo Holdings
The life science investor has started 2022 with an acquisition.
by mikkel aabenhus hemmingsen, translated by catherine brett
Novo Holdings has acquired US-based Medical Knowledge Group, which has developed a platform for launching new drugs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
